Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/08/2009 | WO2009004383A2 Aza-bicyclohexane compounds useful as anticoagulants |
01/08/2009 | WO2009004356A1 Phthalazinone derivatives as inhibitors of parp-1 |
01/08/2009 | WO2009003999A2 Chemical compounds |
01/08/2009 | WO2009003998A2 Antiproliferative compounds based on 5-membered heterocycles |
01/08/2009 | WO2009003861A1 Imidazole derivatives as ccr2 receptor antagonists |
01/08/2009 | WO2009003681A1 Dpp-iv inhibitors |
01/08/2009 | WO2008142720A3 Quinazolin-oxime derivatives as hsp90 inhibitors |
01/08/2009 | WO2008141462A9 Novel case of renin inhibitors |
01/08/2009 | WO2008119720A8 1-(1-cyclobutyl-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine |
01/08/2009 | WO2008100867A3 Novel inhibitors hepatitis c virus replication |
01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
01/08/2009 | WO2008063548A3 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents |
01/08/2009 | WO2008035377A3 Novel intermediates for the preparation of camptothecin analogues |
01/08/2009 | WO2008009210A8 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
01/08/2009 | WO2007087026A9 Solid-state form of amg 706 and pharmaceutical compositions thereof |
01/08/2009 | US20090012290 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
01/08/2009 | US20090012126 Certain chemical entities, compositions, and methods |
01/08/2009 | US20090012124 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors |
01/08/2009 | US20090012123 Protective Agent for Retinal Neuronal Cell Comprising Indazole Derivative as Active Ingredient |
01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
01/08/2009 | US20090012119 Fluoroalkylpyrrolidine derivative |
01/08/2009 | US20090012118 Kynurenic Acid Amide Derivatives as Nr2b Receptor Antagoni |
01/08/2009 | US20090012101 Mucarinic Agonists and Methods of Use Thereof |
01/08/2009 | US20090012089 Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators |
01/08/2009 | US20090012087 New Aza-Bicyclohexane Compounds Useful As Inhibitors Of Thrombin |
01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
01/08/2009 | US20090012082 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
01/08/2009 | US20090012073 N-aroyl cyclic amines |
01/08/2009 | US20090012070 Pesticidal heterocycles |
01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
01/08/2009 | US20090012063 Novel imidazole derivatives |
01/08/2009 | US20090012060 Antitumor Agent |
01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
01/08/2009 | US20090012056 Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor |
01/08/2009 | US20090012055 Piperidine derivatives such as 4-{4-[3-(2-Methoxybenzyloxy)propoxy]phenyl}-3-[3-methoxy-5-(3-methoxypropoxy)benzyloxy]piperidine, suitable as renin inhibitors, used for the treatment of hypertension, heart failure, glaucoma, cardiac infarction, kidney failure or restenosis; improved pharmacokinetics |
01/08/2009 | US20090011994 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
01/08/2009 | DE102006014324B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
01/08/2009 | DE102006014319B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
01/08/2009 | CA2695031A1 Novel substituted piperidones as hsp inducers |
01/08/2009 | CA2694264A1 Substituted piperazines as cb1 antagonists |
01/08/2009 | CA2694253A1 Substituted piperazines as cb1 antagonists |
01/08/2009 | CA2693182A1 Compounds useful as raf kinase inhibitors |
01/08/2009 | CA2692502A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
01/08/2009 | CA2692460A1 Novel hiv reverse transcriptase inhibitors |
01/08/2009 | CA2692383A1 New chemical compounds |
01/08/2009 | CA2692379A1 Antiproliferative compounds based on 5-membered heterocycles |
01/08/2009 | CA2692268A1 Substituted piperazines as cb1 antagonists |
01/08/2009 | CA2692265A1 Amide compounds |
01/08/2009 | CA2692253A1 Gamma secretase modulators |
01/08/2009 | CA2692145A1 Antiviral compounds |
01/08/2009 | CA2691662A1 Imidazole derivatives as ccr2 receptor antagonists |
01/08/2009 | CA2691459A1 Phthalazinone derivatives as inhibitors of parp-1 |
01/08/2009 | CA2691442A1 Antiviral compounds |
01/08/2009 | CA2690753A1 Sulfonamide compound and crystal thereof |
01/07/2009 | EP2011800A2 Inhibitors of caspase |
01/07/2009 | EP2011794A2 Process for the preparation of 5-(3-pyridylmethylene)-imidazolidine-2,4-dione |
01/07/2009 | EP2011787A1 Dying composition comprising an azomethin-type compound with a pyrazolinone moiety |
01/07/2009 | EP2010521A1 Indazole compounds and methods for inhibition of cdc7 |
01/07/2009 | EP2010520A1 Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases |
01/07/2009 | EP2010519A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
01/07/2009 | EP2010518A1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors |
01/07/2009 | EP2010517A1 Vaccine against nicotine addiction |
01/07/2009 | EP2010516A1 Trisubstituted 1,2,4-triazoles |
01/07/2009 | EP2010515A1 2-(pyridin-2-yl)-pyrimidines for use as fungicides |
01/07/2009 | EP2010514A1 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides |
01/07/2009 | EP2010513A2 Novel crystalline compounds |
01/07/2009 | EP2010506A1 Diazepan derivatives modulators of chemokine receptors |
01/07/2009 | EP2010505A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
01/07/2009 | EP2010504A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
01/07/2009 | EP2010497A1 Compositions and methods for modulating gated ion channels |
01/07/2009 | EP2010488A2 Renin inhibitors |
01/07/2009 | EP2010487A1 5-amido-2-carboxamide indoles |
01/07/2009 | EP2010485A1 Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists |
01/07/2009 | EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
01/07/2009 | EP2010289A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol |
01/07/2009 | EP2010178A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
01/07/2009 | EP1807072B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
01/07/2009 | EP1771415B1 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
01/07/2009 | EP1727799B1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
01/07/2009 | EP1678163B1 Novel imidazole derivatives and their use as pharmaceutical agents |
01/07/2009 | EP1562589B1 Diaminotriazoles useful as inhibitors of protein kinases |
01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
01/07/2009 | EP1425277B1 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
01/07/2009 | EP1292300B1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus |
01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
01/07/2009 | EP1001939B1 Heterocyclic substituted 4-benzoyl-pyrazole as herbicides |
01/07/2009 | CN101341148A New salt and polymorph of DPP-IV inhibitor |
01/07/2009 | CN101341147A Substituted heterocyclic compounds with cxcr3 antagonist activity |
01/07/2009 | CN101341146A 3- (4- { [4-(4-{ [3-(3, 3-dimethyl-1-piperidinyl) propyl[oxy] phenyl) -1-piperidinyl carbonyl }-1-naphthalenyl) propanoic or propenoic acid as H1 and H3 receptor antagonists for the treatment of infla |
01/07/2009 | CN101341145A Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
01/07/2009 | CN101341144A Enantioselective preparation of benzimidazole derivatives and their salts |
01/07/2009 | CN101341138A Cyclic anilino-pyridinotriazines as GSK-3 inhibitors |
01/07/2009 | CN101341136A Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
01/07/2009 | CN101341133A Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
01/07/2009 | CN101341129A Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
01/07/2009 | CN101341126A Antibacterial active 5-chinolin derivative |
01/07/2009 | CN101341125A New phenanthridine derivatives as bradykinin antagonists |
01/07/2009 | CN101341124A Six-membered heterocycles useful as serine protease inhibitors |
01/07/2009 | CN101341123A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |